Security key
69012T305
Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)
CUSIP: 69012T305
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Total 13F shares
- 34,194
- Total 13F value
- $37,271
- Share change
- +34,194
- SEC-reported price per share
- $1.09
- Number of holders
- 1
- Value change
- +$37,271
- Number of buys
- 1
- Shares outstanding
- 164,107,590
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
1
Top holders
1
OTLK full security history
Ownership snapshot
Full 13F holder table
Outlook Therapeutics, Inc. SEC filings
Outlook Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Arun Kumar Pillai
Disclosed value leader
Arun Kumar Pillai
Comparable rows
0/15
Latest evidence
31 Dec 2022
3/4/5
13F
Highest disclosed value: $26,085,170
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Arun Kumar Pillai has the largest disclosed position value at $26.09M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Arun Kumar Pillai's linked filing trail.
Disclosed position value
Top 5
Arun Kumar Pillai
$26.09M
Tenshi Healthcare Pte. Ltd.
$26.09M
BlackRock Finance, Inc.
$7.61M
VANGUARD GROUP INC
$6.12M
Altium Capital Management LLC
$3.59M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Arun Kumar Pillai |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$26,085,170
22,982,529 shares
|
— | 01 Feb 2022 |
| Tenshi Healthcare Pte. Ltd. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$26,085,170
22,982,529 shares
|
— | 21 Apr 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$7,609,672
7,045,992 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$6,115,673
5,662,661 shares
|
— | 31 Dec 2022 |
| Altium Capital Management LLC |
13F
Company
|
—
class O/S missing
|
$3,593,596
3,327,404 shares
|
— | 31 Dec 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$2,227,000
2,062,198 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
34,194
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q1 2023 Across Filers
Q1 2023 holders
1
Q1 2023 holders
1
Holder diff
0
| Investor | Q1 2023 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q1 2023 value | Value change | Value Chg % |
|---|